Market Trends of Amniocentesis Needle Industry
This section covers the major market trends shaping the Amniocentesis Needle Market according to our research experts:
Amniocentesis Procedure is Expected to Show Steady Growth Over the Forecast Period
Rising concern about genetic disorders is the major factor responsible for the growing number of procedures. Various studies have been conducted by organizations such as the National Institute of Health (NIH) to understand the risks associated with amniocentesis procedure and the challenges during the same. Studies have revealed that the occurrence of early abortion after amniocentesis is a major risk and its prevalence is around 10%. However, the technical advancements in the needles, and the focus of medical professionals on the safety of the patient, it is expected that the instances of early abortions will be reduced in the near future. Furthermore, the increasing birth rate globally is enhancing market growth. India is the leading country in terms of having the highest birthrate.
Therefore, due to the increasing birth rate, rising number of amniocentesis procedures, growing adoption of the same, and increasing focus on patient safety, the amniocentesis procedure segment is expected to show steady growth over the forecast period.
North America to Maintain Lead in the Amniocentesis Market
The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market over the forecast period. Factors, such as the rising government initiatives and an increasing number of amniocentesis procedures, are driving the growth of the market in this region.
The developed healthcare system in the United States is augmenting the demand for advanced products which is accelerating the growth of amniocentesis needles with advanced technology. Added to that, a concern of the general population in the North America region about the genetic disorders in a newborn is propelling the demand for amniocentesis procedure.